Compounded medication — not FDA-approved
This article discusses compounded medications that are not FDA-approved products. Compounded medications are prepared by licensed 503A/503B pharmacies based on a licensed provider's prescription. They are not evaluated by the FDA for safety or efficacy. Nothing in this article constitutes medical advice, diagnosis, or a recommendation to use any product. All prescribing and dosing decisions are made by a licensed physician during intake.
In this article
what NAD+ actually does
Nicotinamide adenine dinucleotide — NAD+ for short — is a coenzyme in every cell of your body. It's not a hormone or a signaling molecule in the usual sense. Think of it as a kind of metabolic currency. Hundreds of enzymes need NAD+ to do their job, and those enzymes run things like energy production, DNA repair, inflammation control, and your circadian rhythm.
The most-discussed NAD+-dependent enzymes are the sirtuins — SIRT1 through SIRT7. People sometimes call them the "longevity genes" because they appear to be the enzymes that implement the lifespan-extending effects of caloric restriction, exercise, and fasting. All seven sirtuins require NAD+ to function. When NAD+ runs low, sirtuin activity drops.
Another set of enzymes called PARPs also burn through NAD+. Their job is fixing damaged DNA — a critical function, especially in tissues hit with oxidative stress, UV, or chemotherapy agents. Like sirtuins, PARPs run out of function when NAD+ supplies drop.
why oral NAD+ supplements underperform
The supplement industry has responded to NAD+ research with a flood of oral products — NAD+, nicotinamide mononucleotide (NMN), and nicotinamide riboside (NR) capsules. The logic sounds clean: take an NAD+ precursor orally, your body converts it, your cells get more NAD+.
Reality is messier. Direct oral NAD+ has very poor bioavailability — your gut takes the molecule apart before it can reach your bloodstream. Studies estimate less than 5% of an oral NAD+ dose makes it into circulation intact.
Oral NMN and NR improve on this substantially. NR in particular has decent oral bioavailability and does raise blood NAD+ levels measurably.[1] Here's the catch: raising blood NAD+ isn't the same as raising tissue NAD+, and the tissues that matter most for longevity — brain, heart, muscle — appear to be relatively resistant to getting NAD+ from circulating supply. NMN may have slightly better tissue uptake than NR, but the human data is still evolving.
Most published human studies on oral NR have shown modest effects on blood NAD+ and inconsistent effects on downstream biomarkers. Some studies show improvements in aging biomarkers. Others show no effect. That's not the picture you'd expect from a supplement that's genuinely restoring NAD+ to youthful levels.
Key Takeaway
Sources & references
- [1]Martens CR, et al. "Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults." Nature Communications, 2018. ↩
injectable NAD+: the bioavailability argument
Injectable NAD+ skips the GI absorption problem entirely. A subcutaneous or intramuscular injection of NAD+ delivers the molecule directly into the tissue and bloodstream, where cells take it up through the normal channels they use.
Practical effect: injectable NAD+ produces a much bigger rise in measurable NAD+ than any oral protocol, and the effect reaches tissues that oral precursors struggle to affect. The tradeoff: it's a prescription medication rather than an over-the-counter supplement, and it requires injection — usually subcutaneous, the same way insulin gets administered.
Clinical NAD+ protocols are widely used by longevity physicians and anti-aging clinics. The original high-dose protocol — NAD+ IV infusion at 500-1,000mg over several hours — is still used for specific indications (post-addiction recovery, severe neurological conditions) but it's logistically difficult and expensive. The subcutaneous injection protocol, at doses of 100-300mg once or twice weekly, has become the standard for biohacker and longevity use. Cheaper, can be self-administered at home, produces consistent effects.
what patients actually notice
The most common reports from patients on injectable NAD+ protocols:
More energy. Many patients describe the effect as subtle at first, then more apparent after they take a break from the protocol and notice how much they had while on it. Timelines vary.
Better focus and mental stamina. Patients running demanding cognitive schedules — executives, physicians, researchers — frequently call this the most noticeable benefit.
Better exercise recovery. Soreness resolves faster, workout capacity improves. Consistent with NAD+'s role in mitochondrial function in muscle.
Better sleep quality. Not universal, but commonly reported. Hard to attribute cleanly because sleep is affected by so many variables.
What patients usually don't report: a dramatic transformation. NAD+ replacement isn't a stimulant or a mood-altering drug. The effects build gradually and you mostly notice them by comparison to how you felt before. Individual response is assessed with your prescribing provider.
dosing, frequency, and stacking
Specific dosing, frequency, and administration get determined by the prescribing provider based on your health history, bloodwork, and goals. Published research describes a range of approaches, but the protocol for any individual patient is a clinical decision made during intake.
Injectable NAD+ is typically administered subcutaneously. Periodic blood markers (not specifically for NAD+ levels, but for general metabolic health) and physician follow-up are standard parts of a supervised protocol.
NAD+ stacks well with other longevity interventions. The most common pairings in published protocols:
- Rapamycin for the autophagy/mTOR side of longevity - Sermorelin for GH-axis support - Metformin for insulin sensitivity (though this stack question is still unsettled) - Exercise, especially zone 2 — which raises NAD+ levels on its own
Some patients stack oral NMN or NR with injectable NAD+ on non-injection days for continuous support. Whether that adds meaningful benefit beyond the injectable alone isn't clearly established, but the cost is low and the downside is minimal.
safety and side effects
Injectable NAD+ at longevity doses has a strong safety profile. The most common side effects are injection-site reactions (redness, minor soreness) and occasional flushing in the first few minutes after injection. Some patients report transient nausea or a sense of chest pressure with rapid administration — which is why subcutaneous (slower absorption) is preferred over IV for outpatient use.
At IV doses above 500mg given over less than an hour, patients can experience more pronounced flushing and cardiovascular effects. That's why the classic IV NAD+ protocols are run over 4-8 hours, not as a single fast dose. The subcutaneous protocol at 100-300mg essentially never produces these effects because the absorption is gradual.
Contraindications are limited. Pregnancy and nursing are the main ones. Patients with serious kidney or liver problems should discuss with their physician. Patients on chemotherapy should coordinate with their oncologist — the interaction between NAD+ and certain chemo agents is an active research question.
how to actually get NAD+ prescribed
Injectable NAD+ is compounded by 503A pharmacies and requires a physician prescription. Most primary care physicians aren't familiar with longevity-focused NAD+ protocols, so patients typically access it through:
- Telehealth platforms that specialize in longevity protocols - Age management or functional medicine clinics - Direct-pay longevity physicians (Peter Attia-style concierge practices, for instance)
The telehealth route has become the dominant access path because it's available regardless of geography and because the physicians on these platforms actually run the protocols rather than learning them from the patient. A standard intake covers medical history, current medications, goals, and sometimes baseline bloodwork. Prescriptions get filled by a partnered compounding pharmacy and shipped to you.
For patients serious about longevity, NAD+ is one of the foundational interventions. It's well-studied, its age-related decline is well-documented, and injectable delivery solves the bioavailability problems that limit oral supplementation. Not a substitute for the basics of good health — but for patients already doing the basics, NAD+ is one of the clearest incremental levers available.
Frequently asked questions
Is injectable NAD+ better than oral NMN or NR supplements?
For getting NAD+ into your body, yes. Direct oral NAD+ is mostly degraded in the gut — studies estimate under 5% reaches circulation intact. Oral NR and NMN do raise blood NAD+, but the tissues that matter most for longevity (brain, heart, muscle) appear relatively resistant to absorbing it from circulation. An injection bypasses the gut and produces a much larger, tissue-level rise.
How is injectable NAD+ taken?
As a self-administered subcutaneous injection — the same delivery method used for insulin — typically on a weekly basis, with the specific dose set by your prescribing provider based on your history, bloodwork, and goals. Subcutaneous is preferred over IV for at-home use because the slower absorption avoids the flushing and nausea that fast IV dosing can cause.
What does NAD+ do, and what do people notice?
NAD+ is a coenzyme every cell needs for energy production, DNA repair, and sirtuin ('longevity gene') activity, and tissue levels drop 20–50% by midlife. Patients most commonly report gradually improved energy, focus and mental stamina, and exercise recovery, and sometimes better sleep — built up over time rather than a dramatic, stimulant-like effect.
Is injectable NAD+ safe?
At longevity doses given subcutaneously, NAD+ has a strong safety profile. The most common effects are mild injection-site reactions and brief flushing shortly after dosing. Contraindications are limited — mainly pregnancy and nursing — and patients with serious kidney or liver disease, or those on chemotherapy, should coordinate with their physician.
How do you get NAD+ prescribed?
Injectable NAD+ is compounded by a 503A pharmacy and requires a physician prescription. Because most primary care physicians don't run longevity protocols, patients typically access it through a longevity-focused telehealth platform — online intake, provider review, and a prescription filled by a partnered compounding pharmacy and shipped to you.
Editorial & medical disclaimer
This article is published by the Pepvio editorial team for informational purposes only. It is not medical advice, diagnosis, or treatment, and it has not been reviewed by a licensed clinician. The information presented draws on published research but should not substitute for professional medical guidance. Pepvio protocols require a prescription from a licensed healthcare provider. Individual results vary. Always consult your physician before starting any new treatment protocol. Pepvio does not claim that any product cures, treats, or prevents any disease.
Ready to get started?
A short intake form, reviewed by a licensed U.S. physician. You're only charged if a prescription is written.
See if NAD+ is right for meKeep reading
Metformin for Longevity: Why Peter Attia Reconsidered His Position
Peter Attia publicly backed off metformin as a longevity recommendation around 2022-2023, citing research on mitochondrial adaptations to exercise. Here's the full arc — the original rationale, the specific findings that changed his mind, the TAME trial context, and where other longevity clinicians have landed. An authority-content read for anyone tracking the metformin-longevity debate.
Read articleNAD+ Injections vs Oral NMN: Bioavailability, Cost, and Why Biohackers Picked a Side
NAD+ precursors come in several forms — injectable NAD+, oral NMN, oral NR, and IV — and the bioavailability debate between them is one of the more technical arguments in the longevity space. Here's what the published research on tissue-level NAD+ actually shows, how the cost structures compare, and why most informed biohackers have converged on a specific answer.
Read articleQuercetin, Fisetin, and the Senolytic Category: What's Real and What's Hype
Senolytics — compounds that selectively kill senescent cells — are one of the most interesting emerging categories in aging biology. The research is genuinely exciting, the consumer marketing has gotten ahead of the science, and the line between 'promising biology' and 'evidence-based intervention' is especially blurry here. A careful read of the category.
Read article